SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Japan hits Pfizer with business improvement order after ADR reporting failures

Pfizer failed to report hundreds of serious adverse drug reactions (ADRs) in the required timeframes according to Japan’s Ministry of Health, Labor and Welfare (MHLW) which has issued the US firm with a business improvement order.

Pfizer HQ in Japan

Sanofi seeks to expand UK inhalables site with an eye on CMO business

Sanofi wants to expand its inhalable drug production site in Cheshire, UK to increase capacity for both its own brand drug production operations and its contract manufacturing business.

CeQur's $100m financing to scale-up insulin delivery patch-pump production

GLP-1 drugs and oral formulations will not diminish demand for insulin patch-pumps says CeQur, which has raised $100m (€89m) to support production of its PaQ delivery device.

Update - Wholesale cost of Zarxio will be 15% less than Amgen's Neupogen

Biosimilars land in the US as Sandoz launches Zarxio

Sandoz has launched Zarxio, the first biosimilar in the US, despite a last ditch effort to block the copycat version of Neupogen by Amgen.

Pfizer confirms it is evaluating Korea operations amid job cut rumours

Pfizer has confirmed it is in discussion with labour unions in Korea as part of an evaluation of its business in the country.

Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation

Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...